{"id":176446,"date":"2018-01-11T10:21:02","date_gmt":"2018-01-11T10:21:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=176446"},"modified":"2018-01-11T10:21:02","modified_gmt":"2018-01-11T10:21:02","slug":"leprosy-treatment-market-is-expected-to-display-positive-growth-at-a-cagr-of-32-by-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/leprosy-treatment-market-is-expected-to-display-positive-growth-at-a-cagr-of-32-by-2023_176446.html","title":{"rendered":"Leprosy Treatment Market is expected to Display Positive Growth at a CAGR of 3.2% by 2023"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Leprosy Treatment Market”<\/div>\n<\/div>\n<\/div>\n
Leprosy treatment market information: by drug class (sulfone, phenazine, derivative, anti-tubercular drugs, others) by disease type (paucibacillary leprosy, multibacillary leprosy) by market channel (private, contract, others) – Global Forecast till 2023<\/div>\n

The Global Leprosy Treatment Market<\/a> is expected to reach $ 3.5 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 3.2 % during 2017-2023.<\/p>\n

Leprosy is a chronic infection caused by the bacteria Mycobacterium leprae<\/em> or Mycobacterium lepromatosis<\/em> causing granulomas of the nerves, respiratory tract etc. The granulomas may result in lack of ability to feel pain, especially in the extremities such as finger tips. The global market for leprosy is falling due to early detection and awareness campaigns and integration of basic leprosy services into general health services of many countries.<\/p>\n

Get a Sample Report @ <\/strong>https:\/\/www.marketresearchfuture.com\/sample_request\/3862<\/a> .<\/p>\n

Key players of Global Leprosy treatment Market:<\/strong><\/p>\n

Key players profiled in the report are Glaxo Smithcline, Systopic Laboratories Pvt. Ltd., Cadila Pharmaceuticals, Acme Pharmaceuticals, Macleods Pharmaceuticals, Novartis International AG, Astra Zeneca, Lark Laboratories Ltd., and others.<\/p>\n

Segments:<\/strong><\/p>\n

The global leprosy treatment market is segmented on the basis of drug class, disease type and market channel. Based on drug class, the market has been segmented as sulfone, phenazine, derivative, anti-tubercular drugs and others. Based on the disease type, the market has been segmented as paucibacillary leprosy, multibacillary leprosy. Based on the end users, the market has been segmented as private, contract and others.<\/p>\n

Regional analysis<\/strong><\/p>\n

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global leprosy treatment.<\/p>\n

Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most potential and it is estimated to be led by China and India.<\/p>\n

Order Copy of 110 Premium Pages is Available @<\/strong> https:\/\/www.marketresearchfuture.com\/reports\/leprosy-treatment-market-3862<\/a> .<\/p>\n

The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration.<\/p>\n

Brief TOC<\/strong><\/p>\n

    \n
  1. Introduction    <\/li>\n
  2. Research Methodology<\/li>\n
  3. Market Dynamics<\/li>\n
  4. Market Factor Analysis  <\/li>\n
  5. Global Leprosy Treatment Market, By Drug Class<\/li>\n
  6. Global Leprosy Treatment Market, By Disease Type<\/li>\n
  7. Global Leprosy Treatment Market, By Market Channel<\/li>\n
  8. Global Leprosy Treatment Market, By Region  <\/li>\n
  9. Competitive Landscape  <\/li>\n
  10. Company Profile <\/li>\n
  11. Conclusion<\/li>\n
  12. Appendix<\/li>\n<\/ol>\n

    Ask to Expert @ <\/strong>https:\/\/www.marketresearchfuture.com\/enquiry\/3862<\/a> .<\/p>\n

    About US:<\/strong><\/p>\n

    Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.<\/p>\n

    Media Contact<\/span>
    Company Name:<\/strong> Market Research Future
    Contact Person:<\/strong> Akash Anand
    Email:<\/strong> akash.anand@marketresearchfuture.com
    Phone:<\/strong> +1 646 845 9312
    Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
    City:<\/strong> Pune
    State:<\/strong> Maharashtra
    Country:<\/strong> India
    Website:<\/strong>     https:\/\/www.marketresearchfuture.com\/reports\/leprosy-treatment-market-3862<\/a><\/p>\n

    <\/object><\/p>\n

    \"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

    “Leprosy Treatment Market” Leprosy treatment market information: by drug class (sulfone, phenazine, derivative, anti-tubercular drugs, others) by disease type (paucibacillary leprosy, multibacillary leprosy) by market channel (private, contract, others) – Global Forecast till 2023 The Global Leprosy Treatment Market is … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-176446","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/176446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=176446"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/176446\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=176446"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=176446"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=176446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}